February 20, 2019

BONESUPPORT HOLDING AB (publ) – Invitation to conference call in connection of the Full Year Report 2018

Lund, Sweden, 08.00 CET, 20 February 2019 – BONESUPPORT HOLDING AB (publ) -listed on Nasdaq Stockholm - an emerging leader in Orthobiologics for the management of bone voi...
Read more
February 19, 2019

Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019

DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on ...
Read more
February 18, 2019

Oncopeptides will host a webcast in conjunction with its Year-end Report 2018 on 22 February at 14.00 (CET)

Stockholm —18 February 2019 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the Company will release its Year-end Report on 22 February at 8:00 am CET. The r...
Read more
February 15, 2019

Rainier Therapeutics Presents Data on Vofatamab in Patients with Advanced Urothelial Cell Carcinoma (Bladder Cancer) Previously Treated with Chemotherapy at ASCO GU 2019

– Preliminary data from FIERCE-21 Phase 2 trial highlighted in oral presentation supports advancement to pivotal study – – Single agent activity and long-term treatment dura...
Read more
February 14, 2019

Targovax ASA: Fourth quarter and full year 2018 results

Thursday, February 14, 2019 Oslo, Norway, 14 February 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-...
Read more
February 14, 2019

MIPS – Year end report 2018

THU, FEB 14, 2019 07:30 CET OCT - DEC Net sales increased by 53% to SEK 62.2m (40.6). Adjusted for currency exchange rate effects, the increase was 44% Operating profit...
Read more
February 13, 2019

Vicore Pharma postpones publication of year-end report

Mölndal, February 13, 2019 - Vicore Pharma Holding AB (publ) has decided to postpone the publication of the year-end report for 2018. The year-end report will be published on Marc...
Read more
February 13, 2019

Correction of error Q3 (18) report

Lund, Sweden, 08.00 CET, February 13, 2019 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, today announces that the report for the thi...
Read more
February 12, 2019

Intravitreal administration of GS010 in patients with LHON was safe and well tolerated

Paris, France, February 12, 2019, 7:30 a.m. CET – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and deve...
Read more
February 11, 2019

First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma

Monday, February 11, 2019 Trial extended in checkpoint inhibitor refractory melanoma with up to 12 additional patients receiving an increased dosing regimen ...
Read more